Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Most lawmakers will spend the week in their home districts but a select few will gather in New York City for a hearing on what experts say is a looming crisis in home health care services. When the full Legislature returns Feb. 28, lawmakers can look forward to a month of backroom negotiations over the state budget. Democratic Gov. Andrew Cuomo has proposed a $152 billion spending plan. Lawmakers hope to agree on a final budget before April 1, the start of a new fiscal year. Another unresolved issue is Uber's request to expand upstate. Ride-hailing services Uber and Lyft are both prohibited from operating outside of New York City. ___ This story has been corrected to show the home health care services hearing in in New York City, not Albany. Claim: This Week from Albany: Break before budget work.
In New York state government news, the Legislature is taking a break before work on the state budget heats up.

Paragraph: A Berne court found the man guilty of causing bodily harm and spreading the virus which can cause Aids, court secretary Rene Graf told Reuters. He did not give any further details. Prosecutors had sought a sentence of 15 years in jail, according to media reports. "The accused and nobody else is responsible for infecting the 16 people," Swiss news agency SDA quoted court president Urs Herren as saying, adding the man's motive could have been to seek attention, exact revenge, or prove his omnipotence. The 54-year-old from the Swiss capital Berne had consistently denied the charges, blaming the victims for contracting HIV through unprotected sex and intravenous drug use, Swiss media reported. They did not reveal the man's identity or nationality, in accordance with rules on Swiss criminal proceedings. The case came to the attention of the authorities after an HIV-positive patient told a hospital he suspected his infection was linked to acupuncture treatments he received from the man. The majority of the infected individuals were students of a music school run by the man, who also had an acupuncture practice. Some of the victims told the court he stabbed them with a needle from behind during treatment, SDA reported. Police stormed the man's home a week ago after he stopped coming to the trial. The man, who was free on bail, had barricaded himself inside and was armed with a knife, issuing threats to police, according to media reports. Claim: "Swiss court jails ""healer"" for infecting 16 with HIV."
A self-styled healer was sentenced to 12 years and nine months in jail on Friday after a Swiss court found the acupuncturist guilty of infecting 16 people with HIV.

Paragraph: No discussion of cost. The story did an adequate job of summarizing the benefits reported in the study and putting them into context. The story stated that Folfirinox "caused more serious side effects than standard chemo" but never named them nor quantified them. The journal article reports, for example, that: 75 of those in the Folfirinox group (46%) had neutropenia compared with 35 in the Gemcitabine group (21%) 21 of those in the Folfirinox group (13%) had diarrhea compared with 3 in the Gemcitabine group (2%) 15 of those in the Folfirinox group (9%) had sensory neuropathy compared with 0 in the Gemcitabine group Adequate evaluation of the evidence, including a cautionary note from one independent expert. There was no disease-mongering of pancreatic cancer in this story. Two independent sources were quoted. Good sourcing. The focus of the story is comparing the new drug combo with the existing alternative gemcitabine. The story appropriately ended with this independent expert perspective: "doctors are testing other drug combinations to treat pancreatic cancer. She's hopeful that these combinations will work as well or better than Folfirinox, with fewer serious side effects. Folfirinox "is going to be one of a host of options" for patients, Azad says " The story never explained the availability of the drug in the US or even if it's FDA approved. The story referred to it as "newnovel combinationI see it becoming the standard of caregoing to be one of a host of options" but none of those descriptions explains whether it's approved and available now. The story refers to Folfirinox as a new drug and a novel combination, but also offers an independent expert's perspective that "doctors are testing other drug combinations to treat pancreatic cancer. She's hopeful that these combinations will work as well or better than Folfirinox, with fewer serious side effectsand that Folfirinox "is going to be one of a host of options" for patients." It's clear that the story did not rely on a news release. Claim: New drug advances the fight against pancreatic cancer
This story succinctly captures the important take-aways of the new study in terms of survival advantage and quality of life, while employing two key experts for perspective. Pancreatic cancer is typically such a poor-prognosis tumor that research like this is newsworthy.